Market Overview:
The Global Gelatin Polypeptide Plasma Expander Market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for plasma expanders in various applications such as preoperative prevention, extracorporeal circulation and dialysis. In addition, the growing awareness about the benefits of using plasma expanders is also contributing to market growth. Based on type, the global gelatin polypeptide plasma expander market is segmented into 4.0% content, 3.5% content and 3.2% content segments.
Product Definition:
Gelatin Polypeptide Plasma Expander is a protein-based medical device used as a plasma expander. Gelatin Polypeptide Plasma Expanders are important because they can be used to increase blood volume in cases of severe hemorrhage, traumatic injury, or surgery.
4.0% Content:
4.0% content, it's usage and growth factor in the global gelatin polypeptide plasma expander market is expected to grow at a CAGR of XX% over the forecast period. The rising geriatric population across the globe coupled with increasing awareness levels among consumers regarding health & fitness are some of the key factors driving demand for 4%.0% content in gelatin polypeptide plasma expander market over next seven years.
3.5% Content:
3.5% content is a kind of protein-rich solution that is used in the manufacturing process of gelatin polypeptide plasma expanders. It helps to increase the yield and quality of final products by enhancing their gel strength, viscosity, and clarity among other properties.
Application Insights:
Preoperative prevention was the largest application segment in 2017 and is expected to continue its dominance over the forecast period. Gelatin polypeptide plasma expander has been used for various indications, such as cardiovascular diseases, diabetes mellitus, kidney disorders and liver disorders. The increasing prevalence of these chronic conditions is anticipated to boost product demand in this segment.
Extracorporeal circulation and dialysis are other significant applications of gelatin polypeptide plasma expanders that are estimated to grow at a lucrative CAGR during the forecast period owing to rising patient awareness regarding treatment options after heart transplantation surgery or renal transplantation surgery. In addition, growing R&D initiatives by key players for developing advanced products with enhanced benefits is likely to propel market growth over the coming years.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017 owing to the presence of a large number of centers and institutes that useEGP as an alternative to animal-based plasma expander. The U.S.
Asia Pacific Gelatin Polypeptide Plasma Expander Market by Type (4.0% Content, 3.5% Content), By Application (Preoperative prevention, Extracorporeal circulation and dialysis).
Growth Factors:
- Increasing demand for plasma expanders in surgery and critical care settings
- Rising prevalence of chronic diseases and disorders
- Growing number of trauma patients
- Technological advancements in the field of plasma expanders
- Increasing awareness about the benefits of using gelatin polypeptide plasma expanders
Scope Of The Report
Report Attributes
Report Details
Report Title
Gelatin Polypeptide Plasma Expander Market Research Report
By Type
4.0% Content, 3.5% Content, 3.2% Content
By Application
Preoperative prevention, Extracorporeal circulation and dialysis
By Companies
BBraun, Abbott, Wuhan Hualong, Conler Pharm, BBCA Pharm, Shengtai Pharm, Fuzhou Haiwang Fuyao, Chongqing Dikang Changjiang, Wuhan Daan, BBraun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Gelatin Polypeptide Plasma Expander Market Report Segments:
The global Gelatin Polypeptide Plasma Expander market is segmented on the basis of:
Types
4.0% Content, 3.5% Content, 3.2% Content
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Preoperative prevention, Extracorporeal circulation and dialysis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BBraun
- Abbott
- Wuhan Hualong
- Conler Pharm
- BBCA Pharm
- Shengtai Pharm
- Fuzhou Haiwang Fuyao
- Chongqing Dikang Changjiang
- Wuhan Daan
- BBraun
Highlights of The Gelatin Polypeptide Plasma Expander Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 4.0% Content
- 3.5% Content
- 3.2% Content
- By Application:
- Preoperative prevention
- Extracorporeal circulation and dialysis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gelatin Polypeptide Plasma Expander Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gelatin Polypeptide Plasma Expander is a medical device that uses gelatin to expand the size of blood clots. This can help to prevent or reduce the severity of a stroke.
Some of the key players operating in the gelatin polypeptide plasma expander market are BBraun, Abbott, Wuhan Hualong, Conler Pharm, BBCA Pharm, Shengtai Pharm, Fuzhou Haiwang Fuyao, Chongqing Dikang Changjiang, Wuhan Daan, BBraun.
The gelatin polypeptide plasma expander market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gelatin Polypeptide Plasma Expander Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gelatin Polypeptide Plasma Expander Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gelatin Polypeptide Plasma Expander Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gelatin Polypeptide Plasma Expander Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gelatin Polypeptide Plasma Expander Market Size & Forecast, 2020-2028
4.5.1 Gelatin Polypeptide Plasma Expander Market Size and Y-o-Y Growth
4.5.2 Gelatin Polypeptide Plasma Expander Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 4.0% Content
5.2.2 3.5% Content
5.2.3 3.2% Content
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Preoperative prevention
6.2.2 Extracorporeal circulation and dialysis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gelatin Polypeptide Plasma Expander Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gelatin Polypeptide Plasma Expander Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 4.0% Content
9.6.2 3.5% Content
9.6.3 3.2% Content
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Preoperative prevention
9.10.2 Extracorporeal circulation and dialysis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 4.0% Content
10.6.2 3.5% Content
10.6.3 3.2% Content
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Preoperative prevention
10.10.2 Extracorporeal circulation and dialysis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 4.0% Content
11.6.2 3.5% Content
11.6.3 3.2% Content
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Preoperative prevention
11.10.2 Extracorporeal circulation and dialysis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 4.0% Content
12.6.2 3.5% Content
12.6.3 3.2% Content
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Preoperative prevention
12.10.2 Extracorporeal circulation and dialysis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 4.0% Content
13.6.2 3.5% Content
13.6.3 3.2% Content
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Preoperative prevention
13.10.2 Extracorporeal circulation and dialysis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gelatin Polypeptide Plasma Expander Market: Competitive Dashboard
14.2 Global Gelatin Polypeptide Plasma Expander Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BBraun
14.3.2 Abbott
14.3.3 Wuhan Hualong
14.3.4 Conler Pharm
14.3.5 BBCA Pharm
14.3.6 Shengtai Pharm
14.3.7 Fuzhou Haiwang Fuyao
14.3.8 Chongqing Dikang Changjiang
14.3.9 Wuhan Daan
14.3.10 BBraun
